vib1116
mAbexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 6, 2021 (NCT04948099)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06312020 | Phase 2 | May 9, 2024 | Amgen |
| NCT04948099 | Phase 1 | Jul 6, 2021 | Horizon Therapeutics, LLC, Viela Bio |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amgen | For profit | 1 | 1 | 1 | 2024 |
| Horizon Therapeutics, LLC | For profit | 1 | 0 | 1 | 2021 |
| Viela Bio | For profit | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1